Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4626
First Trust Managed Municipal ETF
FMB
$2.06B
| $3.07M | ﹤0.01% |
60,579
+17,852
| +42% | +$915K |
|
4627
iShares ESG Aware 1-5 Year USD Corporate Bond ETF
SUSB
$1.3B
| $3.06M | ﹤0.01% |
+127,203
| New | +$3.09M |
|
4628
PUT
Penske Automotive Group
PAG
$14.4B
| $3.06M | ﹤0.01% |
29,200
+5,500
| +23% | +$590K |
|
4629
PUT
HDFC Bank
HDB
$120B
| $3.06M | ﹤0.01% |
111,200
-69,400
| -38% | -$1.96M |
|
4630
CALL
Iovance Biotherapeutics
IOVA
$3.16B
| $3.05M | ﹤0.01% |
276,300
-160,800
| -37% | -$2.11M |
|
|
SPYM
4631
State Street SPDR Portfolio S&P 500 ETF
SPYM
$169B
| $3.05M | ﹤0.01% |
68,734
+64,434
| +1,498% | +$3.1M |
|
4632
CALL
Morningstar
MORN
$7.78B
| $3.05M | ﹤0.01% |
12,600
+4,200
| +50% | +$1.06M |
|
|
BHVN
4633
PUT
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $3.04M | ﹤0.01% |
20,900
-99,400
| -83% | -$12.7M |
|
4634
PTC Therapeutics
PTCT
$5.98B
| $3.04M | ﹤0.01% |
75,995
-18,312
| -19% | -$642K |
|
4635
Dillards
DDS
$8.76B
| $3.04M | ﹤0.01% |
13,794
+11,952
| +649% | +$3.45M |
|
4636
CALL
Jazz Pharmaceuticals
JAZZ
$15.9B
| $3.04M | ﹤0.01% |
19,500
-62,100
| -76% | -$9.56M |
|
4637
Vident International Equity Strategy
VIDI
$450M
| $3.04M | ﹤0.01% |
136,623
+113,898
| +501% | +$2.81M |
|
4638
PUT
Arrowhead Research
ARWR
$12.2B
| $3.04M | ﹤0.01% |
86,200
-1,600
| -2% | -$60.2K |
|
4639
Trump Media & Technology Group
DJT
$2.3B
| $3.03M | ﹤0.01% |
125,578
+119,570
| +1,990% | +$4.99M |
|
4640
CALL
Asbury Automotive
ABG
$3.78B
| $3.03M | ﹤0.01% |
17,900
-45,700
| -72% | -$7.91M |
|
4641
PUT
DTE Energy
DTE
$29.3B
| $3.03M | ﹤0.01% |
23,900
+10,400
| +77% | +$1.36M |
|
4642
Lightspeed Commerce
LSPD
$1.38B
| $3.03M | ﹤0.01% |
+135,688
| New | +$3.19M |
|
4643
PUT
iShares Global Tech ETF
IXN
$9.42B
| $3.02M | ﹤0.01% |
66,200
+7,100
| +12% | +$359K |
|
4644
CALL
Direxion Daily Regional Banks Bull 3X ETF
DPST
$417M
| $3.02M | ﹤0.01% |
12,550
-2,190
| -15% | -$677K |
|
|
AWTM
4645
DELISTED
AWTM Ultra-Short Duration Enhanced Income ETF
AWTM
| $3.02M | ﹤0.01% |
62,104
+46,098
| +288% | +$2.25M |
|
|
TMHC
4646
DELISTED
Taylor Morrison
TMHC
| $3.02M | ﹤0.01% |
129,203
+30,299
| +31% | +$802K |
|
4647
PUT
Editas Medicine
EDIT
$433M
| $3.01M | ﹤0.01% |
254,800
-35,900
| -12% | -$481K |
|
4648
First Trust Nasdaq Food & Beverage ETF
FTXG
$18.5M
| $3.01M | ﹤0.01% |
+117,427
| New | +$3.16M |
|
4649
CALL
Toast
TOST
$20.1B
| $3.01M | ﹤0.01% |
232,800
+21,500
| +10% | +$356K |
|
4650
PUT
iShares US Medical Devices ETF
IHI
$3.46B
| $3.01M | ﹤0.01% |
59,700
+36,900
| +162% | +$2.01M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.